Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Tourette Syndrome Treatment Market, by Region, 2019-2027 (USD Billion)
1.2.2. Tourette Syndrome Treatment Market, by Product, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Tourette Syndrome Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Tourette Syndrome Treatment Market Dynamics
3.1. Tourette Syndrome Treatment Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rising focus on Tourette Syndrome research
3.1.1.2. Increasing cases of Tourette Syndrome
3.1.2. Market Restraint
3.1.2.1. Lack of awareness in developing region
3.1.2.2. Withdrawal of the drugs in late stages of clinical trials
3.1.3. Market Opportunities
3.1.3.1. Increase in research and development
Chapter 4. Global Tourette Syndrome Treatment Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Tourette Syndrome Treatment Market, by Product
5.1. Market Snapshot
5.2. Global Tourette Syndrome Treatment Market by Product, Performance - Potential Analysis
5.3. Global Tourette Syndrome Treatment Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
5.4. Tourette Syndrome Treatment Market , Sub Segment Analysis
5.4.1. Antipsychotics
5.4.2. Non Antipsychotics
Chapter 6. Global Tourette Syndrome Treatment Market, Regional Analysis
6.1. Tourette Syndrome Treatment Market , Regional Market Snapshot
6.2. North America Tourette Syndrome Treatment Market
6.2.1. U.S. Tourette Syndrome Treatment Market
6.2.1.1. Product breakdown estimates & forecasts, 2018-2027
6.2.2. Canada Tourette Syndrome Treatment Market
6.3. Europe Tourette Syndrome Treatment Market Snapshot
6.3.1. U.K. Tourette Syndrome Treatment Market
6.3.2. Germany Tourette Syndrome Treatment Market
6.3.3. France Tourette Syndrome Treatment Market
6.3.4. Spain Tourette Syndrome Treatment Market
6.3.5. Italy Tourette Syndrome Treatment Market
6.3.6. Rest of Europe Tourette Syndrome Treatment Market
6.4. Asia-Pacific Tourette Syndrome Treatment Market Snapshot
6.4.1. China Tourette Syndrome Treatment Market
6.4.2. India Tourette Syndrome Treatment Market
6.4.3. Japan Tourette Syndrome Treatment Market
6.4.4. Australia Tourette Syndrome Treatment Market
6.4.5. South Korea Tourette Syndrome Treatment Market
6.4.6. Rest of Asia Pacific Tourette Syndrome Treatment Market
6.5. Latin America Tourette Syndrome Treatment Market Snapshot
6.5.1. Brazil Tourette Syndrome Treatment Market
6.5.2. Mexico Tourette Syndrome Treatment Market
6.6. Rest of The World Tourette Syndrome Treatment Market
Chapter 7. Competitive Intelligence
7.1. Top Market Strategies
7.2. Company Profiles
7.2.1. Otsuka Holdings Co. Ltd.
7.2.1.1. Key Information
7.2.1.2. Overview
7.2.1.3. Financial (Subject to Data Availability)
7.2.1.4. Product Summary
7.2.1.5. Recent Developments
7.2.2. AstraZeneca Plc
7.2.3. Boehringer Ingelheim International GmbH
7.2.4. Auspex Pharmaceuticals, Inc.
7.2.5. Reviva Pharmaceuticals Inc.
7.2.6. Mylan NV
7.2.7. Catalyst Pharmaceutical
7.2.8. Pfizer Inc.
7.2.9. Teva Pharmaceuticals
7.2.10. Zydus Pharmaceuticals
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption